Table 10 Difference in means between treatment and control groups for TG at final follow-up

Cabral et al. [57]

− 1.72 mmol/L*

− 3.51 to 0.07

Caraccio et al. [58]

− 0.10 mmol/L*

− 0.46 to 0.26

Duman et al. [60]

− 1.94 mmol/L*

− 3.65 to − 0.24

Iqbal et al. [62]

− 0.10 mmol/L*

− 0.52 to 0.32

Liu et al. [64]

− 0.08 mmol/L**

− 0.26 to 0.10

Mikhail et al. [66]

− 0.11 mmol/L*

− 0.31 to 0.09

Monzani et al. [68]

− 0.81 mmol/L*

− 2.22 to 0.60

Nagasaki et al. [69]

0.12 mmol/L**

− 0.17 to 0.41

Teixeira et al. [74, 75]

− 0.98 mmol/L*

− 3.52 to 1.55